WEBSITE BSE:544545 NSE: TRUALT Inc. Year: 2021 Industry: Breweries & Distilleries
Last updated: 15:59
TruAlt Bioenergy is a leading biofuel company in India with a primary focus on ethanol production. It operates five distilleries in Karnataka with an installed capacity of 2,000 KLPD, making it one of the larger ethanol producers in the country. The company is vertically integrated in the ethanol value chain and sources feedstock from its own promoter-group sugar operations — this makes it easier for them to secure their raw materials. In addition to first-generation ethanol production, TruAlt is diversifying into compressed biogas (CBG) thro...Read More
TruAlt Bioenergy is a leading biofuel company in India with a primary focus on ethanol production. It operates five distilleries in Karnataka with an installed capacity of 2,000 KLPD, making it one of the larger ethanol producers in the country. The company is vertically integrated in the ethanol value chain and sources feedstock from its own promoter-group sugar operations — this makes it easier for them to secure their raw materials. In addition to first-generation ethanol production, TruAlt is diversifying into compressed biogas (CBG) through its subsidiary Leafiniti, exploring second-generation (2G) ethanol, Sustainable Aviation Fuel (SAF) and bio-chemicals. The company also produces co-products including extra-neutral alcohol (ENA), liquid CO₂, and dry ice. It has strategic tie-ups, including an MoU with the Sumitomo Corporation Asia & Oceania for expanding CBG and SAF facilities. Financially, TruAlt has exhibited strong growth — revenues in FY25 increased 13.9% to ₹1,968.5 cr and PAT grew 84.5% to ₹146.6 cr — and is currently raising money from the public through an IPO, with the proceeds to be used for multi-feedstock capacity expansion, working capital and other general corporate purposes. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹2741 Cr.
Stock P/E 18.7
P/B 1.3
Current Price ₹319.7
Book Value ₹ 249.1
Face Value 10
52W High ₹550
Dividend Yield 0%
52W Low ₹ 318
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Jun 2024 | Sep 2024 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|
| Net Sales | 197 | 388 | 304 | 115 |
| Other Income | 15 | 17 | 23 | 15 |
| Total Income | 212 | 405 | 327 | 130 |
| Total Expenditure | 184 | 371 | 262 | 119 |
| Operating Profit | 29 | 34 | 64 | 10 |
| Interest | 35 | 34 | 38 | 39 |
| Depreciation | 16 | 16 | 21 | 21 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 |
| Profit Before Tax | -22 | -16 | 6 | -49 |
| Provision for Tax | -0 | 2 | 1 | -11 |
| Profit After Tax | -22 | -19 | 5 | -38 |
| Adjustments | 0 | -0 | 0 | 0 |
| Profit After Adjustments | -22 | -19 | 5 | -38 |
| Adjusted Earnings Per Share | -3 | -2.6 | 0.7 | -4.4 |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|
| Net Sales | 1223 | 1908 | 1004 |
| Other Income | 57 | 61 | 70 |
| Total Income | 1280 | 1969 | 1074 |
| Total Expenditure | 1035 | 1599 | 936 |
| Operating Profit | 245 | 370 | 137 |
| Interest | 143 | 144 | 146 |
| Depreciation | 57 | 67 | 74 |
| Exceptional Income / Expenses | 0 | 0 | 0 |
| Profit Before Tax | 45 | 159 | -81 |
| Provision for Tax | 13 | 13 | -8 |
| Profit After Tax | 32 | 147 | -74 |
| Adjustments | 0 | 0 | 0 |
| Profit After Adjustments | 32 | 147 | -74 |
| Adjusted Earnings Per Share | 4.2 | 20.7 | -9.3 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 56% | 0% | 0% | 0% |
| Operating Profit CAGR | 51% | 0% | 0% | 0% |
| PAT CAGR | 359% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | NA% | NA% | NA% | NA% |
| ROE Average | 33% | 30% | 30% | 30% |
| ROCE Average | 14% | 12% | 12% | 12% |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 |
|---|---|---|
| Shareholder's Funds | 265 | 769 |
| Minority's Interest | 0 | 0 |
| Borrowings | 980 | 1117 |
| Other Non-Current Liabilities | 113 | 96 |
| Total Current Liabilities | 1061 | 1047 |
| Total Liabilities | 2418 | 3030 |
| Fixed Assets | 1427 | 1826 |
| Other Non-Current Assets | 334 | 142 |
| Total Current Assets | 658 | 1062 |
| Total Assets | 2418 | 3030 |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 |
|---|---|---|
| Opening Cash & Cash Equivalents | 5 | 23 |
| Cash Flow from Operating Activities | 35 | 329 |
| Cash Flow from Investing Activities | -384 | -243 |
| Cash Flow from Financing Activities | 367 | 40 |
| Net Cash Inflow / Outflow | 19 | 126 |
| Closing Cash & Cash Equivalent | 23 | 150 |
| # | Mar 2024 | Mar 2025 |
|---|---|---|
| Earnings Per Share (Rs) | 4.25 | 20.69 |
| CEPS(Rs) | 14.53 | 30.23 |
| DPS(Rs) | 0 | 0 |
| Book NAV/Share(Rs) | 19.27 | 108.87 |
| Core EBITDA Margin(%) | 15.37 | 16.2 |
| EBIT Margin(%) | 15.36 | 15.89 |
| Pre Tax Margin(%) | 3.67 | 8.36 |
| PAT Margin (%) | 2.6 | 7.69 |
| Cash Profit Margin (%) | 7.25 | 11.19 |
| ROA(%) | 1.32 | 5.38 |
| ROE(%) | 27.02 | 33.08 |
| ROCE(%) | 9.64 | 14.2 |
| Receivable days | 88.97 | 60.98 |
| Inventory Days | 47.58 | 35.37 |
| Payable days | 69.75 | 91.76 |
| PER(x) | 0 | 0 |
| Price/Book(x) | 0 | 0 |
| Dividend Yield(%) | 0 | 0 |
| EV/Net Sales(x) | 1.53 | 0.77 |
| EV/Core EBITDA(x) | 7.63 | 3.98 |
| Net Sales Growth(%) | 0 | 55.94 |
| EBIT Growth(%) | 0 | 61.24 |
| PAT Growth(%) | 0 | 361.01 |
| EPS Growth(%) | 0 | 387.03 |
| Debt/Equity(x) | 6.37 | 2.02 |
| Current Ratio(x) | 0.62 | 1.01 |
| Quick Ratio(x) | 0.47 | 0.81 |
| Interest Cover(x) | 1.31 | 2.11 |
| Total Debt/Mcap(x) | 0 | 0 |
| # | Sep 2025 | Dec 2025 |
|---|---|---|
| Promoter | 70.55 | 70.55 |
| FII | 1.3 | 0.93 |
| DII | 7.08 | 6.69 |
| Public | 21.07 | 21.84 |
| Others | 0 | 0 |
| Total | 100 | 100 |
| # | Sep 2025 | Dec 2025 |
|---|---|---|
| Promoter | 6.05 | 6.05 |
| FII | 0.11 | 0.08 |
| DII | 0.61 | 0.57 |
| Public | 1.81 | 1.87 |
| Others | 0 | 0 |
| Total | 8.58 | 8.58 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
